Offering innovative solutions that
empower the scientific community
to discover patient care.

Key Facts

  • Founded in

    1967
  • Over

    100

    Employees

  • Serving

    20+

    Countries

We are investing in technologies  to support and advance cell and  gene therapies in an effort to  support therapeutic companies  that develop novel therapies to  improve patient outcomes.

Our Core Values

We strive to offer innovative solutions that empower the scientific community to discover therapies that improve patient care. The path to bringing novel therapies to patients across a multitude of disease areas begins with life science research and it begins with WPI.

  • Innovation

    At WPI, innovation means the constant pursuit of novel ideas, methods, and technologies that challenge the status quo. We challenge assumptions, always asking "Why?" We are by nature curious and encourage novel ideation. We recognize that innovation is not a solitary endeavor, but thrives in collaborative and diverse settings.

  • Precision

    Precision is woven into the fabric of or work, as we recognize the critical importance of accuracy and attention to detail in the field of biotechnology. From molecular analyses to therapeutic interventions, we uphold the highest standards of precision to ensure the reliability and efficacy of our products and services.

  • Excellence

    Excellence is not just a goal but a standard that permeates every aspect of our operations. We strive for excellence in research, development, and the delivery of solutions that have a positive impact on human health and well-being. Our commitment to excellence is reflected in our rigorous quality control processes and dedication to continuous improvement.

1 of 3

Our Global Reach

World Precision Instruments has an extensive global network, operates in all major regions, and provides a global network of distribution partners. With four offices and distributors around the globe, WPI works with scientists in research labs in pharmaceutical companies and universities to design and manufacture solutions that push the boundaries of discovery and improve the lives of modern people.

Areas of Focus

Our vision is to improve the development of every drug by offering innovative solutions that empower the scientific community to discover therapies that improve patient care.

  • BASIC
    RESEARCH

    WPI supports both in vitro and in vivo model development to perform basic research in understanding physiological systems and identifying complex biology and pathologies associated with human health and disease.

  • EARLY DRUG DISCOVERY

    Our instrumentation is developed to meet the needs of early drug discovery, including the ability to do high-throughput screening, automation of assays and micro-physiological systems, and standardization of cell sensing technologies like transepithelial electrical resistance (TEER) measurements.

  • PRECLINICAL DRUG DEVELOPMENT

    Our technology supports complex model development, including animal models and organ-on-a-chip systems, providing researchers with the tools to identify and validate drugs preclinically to understand mechanism of action, dosage, administration, drug-drug interactions, patient-specific reactions, pharmacokinetics, pharmacodynamics, safety and efficacy.

  • CLINICAL DEVELOPMENT

    We support the development of preclinical models for identification and validation of prognostic and diagnostic biomarkers.